Cash-strapped PhaseBio sued by drug development partner in dispute over experimental therapy


The California-based development partner wants to take over the development of PhaseBio's lead new drug candidate.

Previous Exclusive: Chase moving offices to another downtown Portland tower
Next Louisville-area medical building sells for $7.5M, tenant will remain